CIK 0001680581 · Non-accelerated filer<br>Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474839948
- Phone
- 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-17 | TANG KEVIN 10% owner | Purchase | +50,945 | $3.52 | $179K | 7,080,945 |
| 2026-07-16 | TANG KEVIN 10% owner | Purchase | +116,671 | $3.56 | $415K | 7,030,000 |
| 2026-07-15 | TANG KEVIN 10% owner | Purchase | +107,377 | $3.56 | $382K | 6,913,329 |
| 2026-07-14 | TANG KEVIN 10% owner | Purchase | +53,651 | $3.56 | $191K | 6,730,000 |
| 2026-07-14 | TANG KEVIN 10% owner | Purchase | +75,952 | $3.58 | $272K | 6,805,952 |
| 2026-07-13 | TANG KEVIN 10% owner | Purchase | +12,966 | $3.54 | $46K | 6,676,349 |
| 2026-06-30 | Banks Sonja Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-30 | Dorton Katina Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-30 | Gould Robert J Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-30 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-30 | King Rachel K. Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-30 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-30 | Hill Colin Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-30 | Ezekowitz Alan Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2026-06-26 | Ezekowitz Alan Director | Sale | −18,000 | $3.65 | $66K | 10,927 |
| 2026-04-23 | Lehrer-Graiwer Joshua Director | Grant or award · Stock Option (right to buy) | +64,000 | 64,000 | ||
| 2026-02-02 | Oltmans Curtis Gale Chief Legal Officer | Grant or award · Stock Option (right to buy) | +170,000 | 170,000 | ||
| 2026-02-02 | Tourangeau Greg Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +57,000 | 57,000 | ||
| 2026-02-02 | Musso Alan A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +170,000 | 170,000 | ||
| 2026-02-02 | Gould Robert J Director | Sale | −15,000 | $10.72 | $161K | 454,864 |
Page 1 of 7 · 136 trades